BNP Paribas Financial Markets
CEMI

BNP Paribas Financial Markets’s Chembio diagnostics, Inc. CEMI Stock Holding History

BNP Paribas Financial Markets’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-165
Closed -$73 – 4077
2023
Q1 		$73 Sell
165
-119
-42% -$47 ﹤0.01% 3789
2022
Q4 		$62 Hold
284
– – ﹤0.01% 3969
2022
Q3 		$103 Sell
284
-107
-27% -$73 ﹤0.01% 4647
2022
Q2 		$254 Sell
391
-385
-50% -$256 ﹤0.01% 3982
2022
Q1 		$636 Sell
776
-669
-46% -$624 ﹤0.01% 4006
2021
Q4 		$1.65K Sell
1,445
-23
-2% -$47 ﹤0.01% 4015
2021
Q3 		$3.67K Buy
1,468
+104
+8% +$289 ﹤0.01% 3735
2021
Q2 		$4.05K Sell
1,364
-1,862
-58% -$6.49K ﹤0.01% 3818
2021
Q1 		$11.3K Sell
3,226
-888
-22% -$4.94K ﹤0.01% 3820
2020
Q4 		$19.5K Sell
4,114
-253
-6% -$1.31K ﹤0.01% 3853
2020
Q3 		$21.2K Buy
4,367
+3,637
+498% +$17.2K ﹤0.01% 3817
2020
Q2 		$2.37K Buy
+730
New +$6.93K ﹤0.01% 4163

Other funds holding CEMI

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BNP Paribas Financial Markets's CEMI Position: Q2 2023 in Review

BNP Paribas Financial Markets sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 165 shares — an estimated $73 sold.

BNP Paribas Financial Markets first reported a position in CEMI in Q2 2020 and held it in 12 quarters. The position peaked at $21.2K in Q3 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

  • BNP Paribas Financial Markets reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 165 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $73.
  • BNP Paribas Financial Markets first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 12 quarters.
  • BNP Paribas Financial Markets's Chembio diagnostics, Inc. position peaked at $21.2K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2023, filed 9 Aug 2023.